col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


23 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Molecular Medicine
  original article Date Title Authors   All Authors
1 [GO] 2023―Jan―26 Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS Richa Batra, Rie Uni, Oleh M. Akchurin, Sergio Alvarez-Mulett, Luis G. Gómez-Escobar, Edwin Patino, et al. (+13)
2 [GO] 2022―Dec―12 Host genetic susceptibility underlying SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Brazilian Children Cíntia Barros Santos-Rebouças, Rafael Mina Piergiorge, Cristina dos Santos Ferreira, Raquel de Seixas Zeitel, Alexandra Lehmkuhl Gerber, Marta Cristine Felix Rodrigues, et al. (+9)
3 [GO] 2022―Nov―08 Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial Sergio Fragoso-Saavedra, Isaac Núñez, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Daniel Manzur-Sandoval, Alejandro Quintero-Villegas, et al. (+20)
4 [GO] 2022―Aug―19 Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, Peter Smith, Olivia Ly Lesslar, Gary Deed, Sonya Marshall-Gradisnik
5 [GO] 2022―Aug―03 Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis Samaneh Maleknia, Mohammad Javad Tavassolifar, Faezeh Mottaghitalab, Mohammad Reza Zali, Anna Meyfour
6 [GO] 2022―Apr―09 The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo Lucía Beltrán-Camacho, Sara Eslava-Alcón, Marta Rojas-Torres, Daniel Sánchez-Morillo, Mª Pilar Martinez-Nicolás, Victoria Martín-Bermejo, et al. (+5)
7 [GO] 2021―Dec―27 Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection Svetlana P. Chapoval, Achsah D. Keegan
8 [GO] 2021―Dec―20 Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection Catherine Chen, Aisah Amelia, George W. Ashdown, Ivo Mueller, Anna K. Coussens, Emily M. Eriksson
9 [GO] 2021―Dec―20 Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach Jamilet Miranda, Ricardo Bringas, Jorge Fernandez-de-Cossio, Yasser Perera-Negrin
10 [GO] 2021―Dec―03 Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 Dong Zhang, Liubing Li, Yu Chen, Jie Ma, Yanli Yang, Surita Aodeng, et al. (+6)
11 [GO] 2021―Oct―18 CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study Nicola I. Lorè, Rebecca De Lorenzo, Paola M. V. Rancoita, Federica Cugnata, Alessandra Agresti, Francesco Benedetti, et al. (+36)
12 [GO] 2021―Sep―26 Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues Martin Begemann, Oliver Gross, Dominik Wincewicz, Rüdiger Hardeland, Vinicius Daguano Gastaldi, Eduard Vieta, et al. (+4)
13 [GO] 2021―Sep―16 Extreme immunotherapy: emergency immunology to defeat pandemics Douglas F. Nixon, Daniela Marín-Hernández, Nathaniel Hupert
14 [GO] 2021―Sep―09 Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry Rodrigo R. R. Duarte, Dennis C. Copertino, Luis P. Iñiguez, Jez L. Marston, Yaron Bram, Yuling Han, et al. (+4)
15 [GO] 2021―May―31 Heterologous vaccine interventions: boosting immunity against future pandemics Daniela Marín-Hernández, Douglas F. Nixon, Nathaniel Hupert
16 [GO] 2021―May―22 Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines Jianhua Li, Ping Wang, Kevin J. Tracey, Haichao Wang
17 [GO] 2021―Mar―26 Essential properties and pitfalls of colorimetric Reverse Transcription Loop-mediated Isothermal Amplification as a point-of-care test for SARS-CoV-2 diagnosis Bruna de Oliveira Coelho, Heloisa Bruna Soligo Sanchuki, Dalila Luciola Zanette, Jeanine Marie Nardin, Hugo Manuel Paz Morales, Bruna Fornazari, et al. (+2)
18 [GO] 2020―Nov―10 SARS-CoV-2 and interferon blockade Betty Diamond, Bruce T. Volpe, Sonya VanPatten, Yousef Al Abed
19 [GO] 2020―Oct―29 IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19 Yu Chen, Jinglan Wang, Chenxi Liu, Longxiang Su, Dong Zhang, Junping Fan, et al. (+6)
20 [GO] 2020―Sep―29 Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series Andrew G. Weber, Alice S. Chau, Mikala Egeblad, Betsy J. Barnes, Tobias Janowitz
21 [GO] 2020―Aug―17 Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19? Pawel Namsolleck, Gert N. Moll
22 [GO] 2020―Jun―16 Erythropoietin as candidate for supportive treatment of severe COVID-19 Hannelore Ehrenreich, Karin Weissenborn, Martin Begemann, Markus Busch, Eduard Vieta, Kamilla W. Miskowiak
23 [GO] 2020―May―07 Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Ulf Andersson, William Ottestad, Kevin J. Tracey
 [1] 

23 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec